Oellerich, T., Schneider, C., Thomas, D., Knecht, K. M., Buzovetsky, O., Kaderali, L., . . . Cinatl, J. (2019). Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML. Nature Portfolio.
Style de citation Chicago (17e éd.)Oellerich, Thomas, et al. Selective Inactivation of Hypomethylating Agents by SAMHD1 Provides a Rationale for Therapeutic Stratification in AML. Nature Portfolio, 2019.
Style de citation MLA (8e éd.)Oellerich, Thomas, et al. Selective Inactivation of Hypomethylating Agents by SAMHD1 Provides a Rationale for Therapeutic Stratification in AML. Nature Portfolio, 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.